Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination

被引:1
作者
Awadalla, Maaweya [1 ]
Alrawi, Halah Z. [1 ]
Henawi, Rahaf A. [1 ]
Barnawi, Fawziya [2 ]
Alkadi, Haitham [1 ]
Alyami, Ahmed [2 ]
Alsughayir, Ammar [2 ]
Alsaif, Alyazeed S. [2 ]
Mubarak, Ayman [3 ]
Alturaiki, Wael [4 ]
Alosaimi, Bandar [1 ]
机构
[1] King Fahad Med City, Riyadh Hlth Cluster 2, Res Ctr, Riyadh, Saudi Arabia
[2] King Fahad Med City, Pathol & Clin Lab Med Adm, Riyadh Hlth Cluster 2, Riyadh, Saudi Arabia
[3] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia
[4] Majmaah Univ, Coll Appl Med Sci, Dept Med Lab Sci, Majmaah, Saudi Arabia
来源
FRONTIERS IN IMMUNOLOGY | 2025年 / 16卷
关键词
humoral; cellular; durability; COVID-19; vaccine; homologous; heterologous; boosters; SARS-COV-2;
D O I
10.3389/fimmu.2025.1526444
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction The durability of Hybrid immunity induced by natural infection and/or COVID-19 vaccines and evidence supporting further booster vaccination are crucial factors for pandemic response, yet remain poorly understood.Methods We measured the durability of immune response and neutralizing capacity of antibodies following Homologous/Heterologous vaccination by mRNA-based vaccines (Pfizer-BioNTech BNT162b2) or (Moderna mRNA-1273) and viral vector-based vaccines (ChAdox1 nCoV-19-Oxford-AstraZeneca) in infected and non-infected patients. We also evaluated the long-lasting specific humoral IgG levels and T-cell immunity of the Memory CD8 cells.Results We found that heterologous prime boosters led to significantly higher IgG antibody levels)9.09(than homologous boosters)5.236) one year after vaccination. We measured SARS-CoV-2 anti-S IgG antibodies and then assessed their neutralizing capacity to inhibit the receptor-binding domain (RBD) of the SARS-CoV-2 wild-type strain and omicron B.1.1.529/BA.2 variants from binding to the ACE2 receptors. The heterologous regiment demonstrated superior ACE2-binding inhibition and consistently had higher mean ACE2-receptor binding inhibition across all dose regimens without the need for further doses. The CD8+ T cells producing IFN-gamma to various COVID-19 vaccine dose regimens were evaluated. We found that robust T cell mediated immune responses were preserved and largely induced by a heterogeneous vaccination eliciting a significantly higher CD8+ T cells IFN-gamma response in 100% of vaccinees regardless of previous natural infection. Indeed, the difference between infected and na & iuml;ve groups was less pronounced suggesting a reduced infection-related response.Discussion Across three layers of evidence, this study showed that heterologous vaccination provides longer-lasting immunity than homologous doses, regardless of prior natural infection.
引用
收藏
页数:11
相关论文
共 30 条
[1]   Homologous and Heterologous Covid-19 Booster Vaccinations [J].
Atmar, R. L. ;
Lyke, K. E. ;
Deming, M. E. ;
Jackson, L. A. ;
Branche, A. R. ;
El Sahly, H. M. ;
Rostad, C. A. ;
Martin, J. M. ;
Johnston, C. ;
Rupp, R. E. ;
Mulligan, M. J. ;
Brady, R. C. ;
Frenck, R. W., Jr. ;
Backer, M. ;
Kottkamp, A. C. ;
Babu, T. M. ;
Rajakumar, K. ;
Edupuganti, S. ;
Dobrzynski, D. ;
Coler, R. N. ;
Posavad, C. M. ;
Archer, J., I ;
Crandon, S. ;
Nayak, S. U. ;
Szydlo, D. ;
Zemanek, J. A. ;
Islas, C. P. Dominguez ;
Brown, E. R. ;
Suthar, M. S. ;
McElrath, M. J. ;
McDermott, A. B. ;
Montefiori, D. C. ;
Eaton, A. ;
Neuzil, K. M. ;
Stephens, D. S. ;
Roberts, P. C. ;
Beigel, J. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (11) :1046-1057
[2]   Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis [J].
Au, Wing Ying ;
Cheung, Peter Pak-Hang .
BMJ-BRITISH MEDICAL JOURNAL, 2022, 376
[3]   Waning Humoral Response after COVID-19 mRNA Vaccination in Maintenance Dialysis Patients and Recovery after a Complementary Third Dose [J].
Biedunkiewicz, Bogdan ;
Tylicki, Leszek ;
Slizien, Waldemar ;
Lichodziejewska-Niemierko, Monika ;
Dabrowska, Malgorzata ;
Kubanek, Alicja ;
Rodak, Sylwia ;
Polewska, Karolina ;
Tylicki, Piotr ;
Renke, Marcin ;
Debska-Slizien, Alicja .
VACCINES, 2022, 10 (03)
[4]   BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection [J].
Cao, Yunlong ;
Yisimayi, Ayijiang ;
Jian, Fanchong ;
Song, Weiliang ;
Xiao, Tianhe ;
Wang, Lei ;
Du, Shuo ;
Wang, Jing ;
Li, Qianqian ;
Chen, Xiaosu ;
Yu, Yuanling ;
Wang, Peng ;
Zhang, Zhiying ;
Liu, Pulan ;
An, Ran ;
Hao, Xiaohua ;
Wang, Yao ;
Feng, Rui ;
Sun, Haiyan ;
Zhao, Lijuan ;
Zhang, Wen ;
Zhao, Dong ;
Zheng, Jiang ;
Yu, Lingling ;
Li, Can ;
Zhang, Na ;
Wang, Rui ;
Niu, Xiao ;
Yang, Sijie ;
Song, Xuetao ;
Chai, Yangyang ;
Hu, Ye ;
Shi, Yansong ;
Zheng, Linlin ;
Li, Zhiqiang ;
Gu, Qingqing ;
Shao, Fei ;
Huang, Weijin ;
Jin, Ronghua ;
Shen, Zhongyang ;
Wang, Youchun ;
Wang, Xiangxi ;
Xiao, Junyu ;
Xie, Xiaoliang Sunney .
NATURE, 2022, 608 (7923) :593-+
[5]   DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice [J].
Chen, Jinni ;
Deng, Yao ;
Huang, Baoying ;
Han, Di ;
Wang, Wen ;
Huang, Mengjing ;
Zhai, Chengcheng ;
Zhao, Zhimin ;
Yang, Ren ;
Zhao, Ying ;
Wang, Wenling ;
Zhai, Desheng ;
Tan, Wenjie .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[6]   To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination [J].
Chiu, Nan-Chang ;
Chi, Hsin ;
Tu, Yu-Kang ;
Huang, Ya-Ning ;
Tai, Yu-Lin ;
Weng, Shun-Long ;
Chang, Lung ;
Huang, Daniel Tsung-Ning ;
Huang, Fu-Yuan ;
Lin, Chien-Yu .
EXPERT REVIEW OF VACCINES, 2021, 20 (10) :1211-1220
[7]   Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines [J].
Collier, Ai-ris Y. ;
Yu, Jingyou ;
McMahan, Katherine ;
Liu, Jinyan ;
Chandrashekar, Abishek ;
Maron, Jenny S. ;
Atyeo, Caroline ;
Martinez, David R. ;
Ansel, Jessica L. ;
Aguayo, Ricardo ;
Rowe, Marjorie ;
Jacob-Dolan, Catherine ;
Sellers, Daniel ;
Barrett, Julia ;
Ahmad, Kunza ;
Anioke, Tochi ;
VanWyk, Haley ;
Gardner, Sarah ;
Powers, Olivia ;
Bondzie, Esther A. ;
Wan, Huahua ;
Baric, Ralph S. ;
Alter, Galit ;
Hacker, Michele R. ;
Barouch, Dan H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (21) :2010-2012
[8]   Viral targets for vaccines against COVID-19 [J].
Dai, Lianpan ;
Gao, George F. .
NATURE REVIEWS IMMUNOLOGY, 2021, 21 (02) :73-82
[9]   Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients [J].
Davidovic, Tamara ;
Schimpf, Judith ;
Abbassi-Nik, Armin ;
Stockinger, Richard ;
Sprenger-Maehr, Hannelore ;
Lhotta, Karl ;
Zitt, Emanuel .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[10]   SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses [J].
Dejnirattisai, Wanwisa ;
Huo, Jiandong ;
Zhou, Daming ;
Zahradnik, Jiri ;
Supasa, Piyada ;
Liu, Chang ;
Duyvesteyn, Helen M. E. ;
Ginn, Helen M. ;
Mentzer, Alexander J. ;
Tuekprakhon, Aekkachai ;
Nutalai, Rungtiwa ;
Wang, Beibei ;
Dijokaite, Aiste ;
Khan, Suman ;
Avinoam, Ori ;
Bahar, Mohammad ;
Skelly, Donal ;
Adele, Sandra ;
Johnson, Sile Ann ;
Amini, Ali ;
Ritter, Thomas G. ;
Mason, Chris ;
Dold, Christina ;
Pan, Daniel ;
Assadi, Sara ;
Bellass, Adam ;
Omo-Dare, Nicola ;
Koeckerling, David ;
Flaxman, Amy ;
Jenkin, Daniel ;
Aley, Parvinder K. ;
Voysey, Merryn ;
Clemens, Sue Ann Costa ;
Naveca, Felipe Gomes ;
Nascimento, Valdinete ;
Nascimento, Fernanda ;
da Costa, Cristiano Fernandes ;
Resende, Paola Cristina ;
Pauvolid-Correa, Alex ;
Siqueira, Marilda M. ;
Baillie, Vicky ;
Serafin, Natali ;
Kwatra, Gaurav ;
Da Silva, Kelly ;
Madhi, Shabir A. ;
Nunes, Marta C. ;
Malik, Tariq ;
Openshaw, Peter J. M. ;
Baillie, J. Kenneth ;
Semple, Malcolm G. .
CELL, 2022, 185 (03) :467-+